Digital 4th Annual Antifibrotic Drug Development Summit

Kongressthemen
Now in its 4th year, the digital AFDD summit is the industry’s definitive guide to turning mechanistic understanding of fibrosis into clinically effective therapeutics across disease areas. With 3 days of in-depth cutting-edge case studies and the highest calibre of discussions from cross-disciplinary fibrosis heavy-weights, AFDD will bridge the current translational gap to anti-fibrotic drug development success

Zielpublikum
500

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Speakers: Andrew Billin Senior Director, Biomarker Sciences Gilead, Bob Willette Senior Fibrosis Advisor ImmunoMet and more.

Brochure: https://go.evvnt.com/680187-4?pid=4832

http://go.evvnt.com/680187-3?pid=4832

Herr Charlotte Harrison